SMTL ID : 8zmf.1

Crystal structure of an inverse agonist antipsychotic drug derivative-bound 5-HT2C

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.60 Å

Oligo State

monomer

Ligands

1 x 01: 1-[(4-fluorophenyl)methyl]-1-[(8~{S})-5-methyl-5-azaspiro[2.5]octan-8-yl]-3-[[4-(2-methylpropoxy)phenyl]methyl]urea

01.1: 21 residues within 4Å: Chain A: W.117, D.121, V.122, S.125, T.126, I.129, V.172, I.176, L.196, F.201, V.202, G.205, S.206, A.209, F.210, F.358, W.362, F.365, F.366, V.392, Y.396 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.122, A:V.122, A:V.172, A:I.176, A:L.196, A:F.201, A:A.209, A:W.362, A:F.366, A:F.366 Hydrogen bonds: A:Y.396 Salt bridges: A:D.121 pi-Stacking: A:W.362

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Oguma, T. et al., Dual 5-HT 2A and 5-HT 2C Receptor Inverse Agonist That Affords In Vivo Antipsychotic Efficacy with Minimal hERG Inhibition for the Treatment of Dementia-Related Psychosis. J.Med.Chem. (2024)

Release Date

2024-08-28

Peptides

5-hydroxytryptamine receptor 2C,Soluble cytochrome b562: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

5-hydroxytryptamine receptor 2C,Soluble cytochrome b562